LitAlert ~~ GeneLit.com

    • Prevalence of BRCA1 and BRCA2 mutations in Japanese patients with triple-negative breast cancer: A single institute retrospective study.
    • Fujisawa F, Tamaki Y, Inoue T, Nakayama T, Yagi T, Kittaka N, Yoshinami T, Nishio M, Matsui S, Kusama H, Kamiura S.
    • Mol Clin Oncol. 2021 May;14(5):96. doi: 10.3892/mco.2021.2258. Epub 2021 Mar 12.
    • Olaparib for the treatment of metastatic prostate cancer.
    • Dror CM, Wyatt AW, Chi KN.
    • Future Oncol. 2021 Mar 26. doi: 10.2217/fon-2020-1245. Epub ahead of print.
    • Review
    • Overview of recent advances in metastatic triple negative breast cancer.
    • O'Reilly D, Sendi MA, Kelly CM.
    • World J Clin Oncol. 2021 Mar 24;12(3):164-182. doi: 10.5306/wjco.v12.i3.164.
    • Preclinical evaluation of radiation therapy of BRCA1-associated mammary tumors using a mouse model.
    • Cho EJ, Kim JK, Baek HJ, Kim SE, Park EJ, Choi BK, Kim TH, Shin DH, Lim YK, Deng CX, Kim SS.
    • Int J Biol Sci. 2021 Jan 31;17(3):689-701. doi: 10.7150/ijbs.53667.
    • The role of novel poly (ADP-ribose) inhibitors in the treatment of locally advanced and metastatic Her-2/neu negative breast cancer with inherited germline BRCA1/2 mutations. A review of the literature.
    • Pop L, Suciu I, Ionescu O, Bacalbasa N, Ionescu P.
    • J Med Life. 2021 Jan-Mar;14(1):17-20. doi: 10.25122/jml-2020-0132.